(Reuters) -U.S. Bancorp announced on Tuesday that President Gunjan Kedia will become its chief executive, effective April 15, ...
(Reuters) - Caroline Kennedy, a member of the famed U.S. political family, urged senators on Tuesday to reject her cousin ...
NEW YORK (Reuters) - Turbulence in some of the biggest tech names is reminding investors of one of the major risks to the U.S ...
MIAMI (Reuters) - Point72 Asset Management's founder Steven Cohen said on Tuesday that the recent developments announced by Chinese artificial intelligence startup DeepSeek are positive for the ...
Airbus has already absorbed 1.6 billion euros ($1.67 billion) of charges for its Space business, which industry sources have ...
Shares of Tectonic plummeted 41% Tuesday following news that a similar drug developed by Eli Lilly (NYSE: LLY) for chronic ...
A cornerstone of Trump's vision includes a phased rollout of universal tariffs on all U.S. imports. His recently confirmed ...
Investing.com -- Shares of Alibaba (NYSE: NYSE: BABA) climbed 2.8% as the company's latest AI model, Qwen2.5-Max, garnered significant interest. The company announced the impressive performance ...
MEXICO CITY (Reuters) - Mexico's Senate will use a drawing to choose the candidates to compete for judge and magistrate ...
(Reuters) -Oil and gas producer Chevron (NYSE: CVX) said on Tuesday it plans to build natural gas-based power plants next to data centers in the U.S., as energy demand to support the growth of ...
Nvidia shares slumped about 17% or close to $593 billion in market value - a record one-day loss for any company - on Monday ...
The FDA's approval is based on the results of the FLOW phase 3b kidney outcomes trial. The trial revealed that Ozempic® 1 mg significantly lowered the relative risk of worsening kidney disease, kidney ...